PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2009938-5	1991	In contrast, in six dogs whose plasma potassium concentration increased in each case by more than 2.0 mEq/l (infusion rate of 0.5 mEq/kg/h), portal insulin levels increased fivefold (p less than 0.05).	Potassium	38-47	insulin	Canis lupus familiaris	148-155	
9174520-10	1997	Insulin-treated animals were characterized by improved cardiodynamics and hemodynamics, increased myocardial glucose uptake, and decreased serum potassium.	Potassium	145-154	insulin	Canis lupus familiaris	0-7	
1935303-2	1991	The control mean serum potassium concentration of 3.65 mEq/L was decreased to 2.14 mEq/L by insulin and furosemide administration.	Potassium	23-32	insulin	Canis lupus familiaris	92-99	
621284-4	1978	A similar rise in serum potassium was observed in normal conscious dogs given somatostatin and was reversed by insulin replacement.	Potassium	24-33	insulin	Canis lupus familiaris	111-118	
2190930-7	1990	Possible mechanisms whereby insulin could increase angiotensin II-stimulated aldosterone production include: increased intracellular potassium, reduced plasma free fatty acids, and a direct action of insulin to induce increased adrenal steroidogenesis.	Potassium	133-142	insulin	Canis lupus familiaris	28-35	
2180321-5	1990	Insulin caused transient sodium and potassium retention followed by renal "escape" that was associated with increased glomerular filtration rate (12-27%).	Potassium	36-45	insulin	Canis lupus familiaris	0-7	
3700233-6	1986	A glucose-insulin-potassium solution was used to treat septic shock in the dog that recovered.	Potassium	18-27	insulin	Canis lupus familiaris	10-17	
3902485-2	1985	A potassium concentration above 15 mMol/l shortly stimulates the insulin and glucagon secretion.	Potassium	2-11	insulin	Canis lupus familiaris	65-72	
3902485-3	1985	Potassium ions (greater than or equal to 15 mMol/l) completely inhibit the early phase of glucose-induced insulin release.	Potassium	0-9	insulin	Canis lupus familiaris	106-113	
6424513-1	1984	The object of this study was to determine whether high doses of insulin administered preventively in combination with glucose and potassium exert a protective effect upon the myocardium.	Potassium	130-139	insulin	Canis lupus familiaris	64-71	
6256174-7	1980	These results show that there was a relation between the levels of blood glucose and serum potassium after an insulin-containing hexose infusion and that membrane permeability was stereospecific.	Potassium	91-100	insulin	Canis lupus familiaris	110-117	
6997645-1	1980	The purpose of this study was to investigate whether pyruvate (2.5 mmol/kg), the combination of glucose (3.9 mmol/kg) and insulin (0.13 unit/kg) with potassium (9.27 meq/kg), or sodium dichloroacetate (120 mg/kg) infused for 15 minutes before and 20 minutes after ligation of the left anterior descending coronary arterv in anesthetized dogs restricted the depression in mitochondrial respiratory function induced by ischemia.	Potassium	150-159	insulin	Canis lupus familiaris	122-129	
94410-6	1979	The intravenous administration of 80 units crystalline zinc insulin produced both hypokalemia (3.78 +/- 0.22 reduced to 2.36 +/- 0.18 mEq potassium/liter plasma) and a reappearance of ventricular tachycardia despite no change in plasma and myocardial tissue concentrations of disopyramide from those which had been effective in establishing and maintaining sinus rhythm.	Potassium	138-147	insulin	Canis lupus familiaris	60-67	
847391-2	1977	0.5 IE insulin/kg bodyweight intravenously was followed by an immediate gastric relaxation, obvious before any marked decrease of blood glucose or plasma potassium occurred, and furthermore not affected by administration of glucose or potassium.	Potassium	154-163	insulin	Canis lupus familiaris	7-14	
3323013-5	1987	Infusion of insulin in this Series elicited smaller decrease in plasma potassium concentration and longer lasting hypernatremia than in dogs in water-electrolytes balance.	Potassium	71-80	insulin	Canis lupus familiaris	12-19	
3323013-7	1987	Infusion of insulin in Series 1 elicited increase of sodium excretion and decrease in potassium excretion.	Potassium	86-95	insulin	Canis lupus familiaris	12-19	
3323013-9	1987	The results indicate that depletion of electrolytes and blood aldosterone elevation modify the effects of insulin on plasma concentration and renal excretion of sodium and potassium.	Potassium	172-181	insulin	Canis lupus familiaris	106-113	
3546914-0	1986	Augmented aldosterone and insulin responses to potassium infusion in dogs with renal failure.	Potassium	47-56	insulin	Canis lupus familiaris	26-33	
3546914-1	1986	The present study examines acute potassium-induced insulin and aldosterone responses in renal failure, and the role of chronic dietary potassium intake in modifying these acute responses.	Potassium	33-42	insulin	Canis lupus familiaris	51-58	
6339594-4	1983	This was particularly evident in the presence of an increased potassium concentration (6 mM) when insulin hyperpolarized infarcting cells (n = 8) from 73 +/- 6 to 85 +/- 7 mV (p less than 0.01).	Potassium	62-71	insulin	Canis lupus familiaris	98-105	
7018811-2	1981	Potassium infusion causes an increase in immunoreactive insulin levels in dogs, but either a small (30%) or no increase in humans.	Potassium	0-9	insulin	Canis lupus familiaris	56-63	
719960-12	1978	Pronounced rises in plasma insulin immunoreactivities during salbutamol infusions suggested this as one mechanism for potassium shifts.	Potassium	118-127	insulin	Canis lupus familiaris	27-34	
206480-0	1978	Epinephrine enhancement of potassium-stimulated immunoreactive insulin secretion.	Potassium	27-36	insulin	Canis lupus familiaris	63-70	
4809620-0	1974	Effect of intrapancreatic injection of potassium and calcium on insulin and glucagon secretion in dogs.	Potassium	39-48	insulin	Canis lupus familiaris	64-71	
5711901-0	1968	Insulin-potassium effect on gastric acid secretion and antral motility in dogs.	Potassium	8-17	insulin	Canis lupus familiaris	0-7	
621284-7	1978	Addition of replacement doses of insulin to the somatostatin infusion resulted in increments in serum potassium which were comparable to infusion of KCl alone.	Potassium	102-111	insulin	Canis lupus familiaris	33-40	
621284-11	1978	It is concluded that (a) potassium homeostasis is influenced by basal insulin levels in the absence of which serum potassium concentration rises and potassium tolerance declines; (b) this effect of insulin is mediated via extrarenal mechanisms of potassium disposal; (c) somatostatin has a biphasic effect on urinary sodium secretion, the mechanism of which remains to be established.	Potassium	25-34	insulin	Canis lupus familiaris	70-77	
16734088-8	2006	Time from admission to initiation of subcutaneous insulin therapy was correlated with lower serum potassium concentration (P = .0056), lower serum phosphorus concentration (P = .0043), abnormally high white blood cell count (P = .0060), large base deficit (P = .0015), and low venous pH (P < .001).	Potassium	98-107	insulin	Canis lupus familiaris	50-57	
21612807-2	2012	Potassium and glucose cellular uptake are intimately linked by insulin.	Potassium	0-9	insulin	Canis lupus familiaris	63-70	
21612807-3	2012	We hypothesized that in canine hypoadrenocorticism, hyperkalaemia would stimulate insulin release as a protective mechanism, translocating potassium from the extracellular compartment to the intracellular compartment and also lower glucose concentrations.	Potassium	139-148	insulin	Canis lupus familiaris	82-89	
15333402-5	2004	In the insulin-glucose-potassium (IGK) group (n = 7), an IV bolus of regular insulin (2 U/kg) was given, followed by a glucose infusion (2 mL/kg of 50% dextrose in water) for 30 min and a potassium infusion (1-2 mmol.	Potassium	23-32	insulin	Canis lupus familiaris	7-14